يعرض 1,061 - 1,080 نتائج من 13,266 نتيجة بحث عن '(( significant increase decrease ) OR ( significantly ((nn decrease) OR (greater decrease)) ))', وقت الاستعلام: 0.42s تنقيح النتائج
  1. 1061
  2. 1062

    Mechlorethamine gel causes epithelium thinning, epithelium-stroma separation, and decreased total stroma cell count. حسب Ana M. Sandoval-Castellanos (11611315)

    منشور في 2025
    "…<p>A) Epithelium thickness decreased, and B) the percentage of epithelium-stroma separation increased after NM exposure. …"
  3. 1063
  4. 1064

    Coefficient plot of short-run effects. حسب Ryan P. Thombs (9138968)

    منشور في 2025
    الموضوعات:
  5. 1065

    Seven forecast scenarios. حسب Ryan P. Thombs (9138968)

    منشور في 2025
    الموضوعات:
  6. 1066
  7. 1067

    Coefficient plot of long-run effects. حسب Ryan P. Thombs (9138968)

    منشور في 2025
    الموضوعات:
  8. 1068
  9. 1069
  10. 1070

    Forecast for each scenario, 2023-2032. حسب Ryan P. Thombs (9138968)

    منشور في 2025
    الموضوعات:
  11. 1071

    Summary of study eligibility criteria. حسب Biban Gill (1473337)

    منشور في 2025
    "…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …"
  12. 1072

    Summary of study participation and feasibility. حسب Biban Gill (1473337)

    منشور في 2025
    "…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …"
  13. 1073

    NPF-NPFR pathway in LNd-LPN feedback circuit fine-tune cooling induced locomotion increase. حسب Xin Yuan (174619)

    منشور في 2024
    "…(C, D) Optogenetic activation of LNds using CsChrimson (<i>DvPdf-Gal4>Uas-CsChrimson</i>, red line) decreases sleep and this decrease effect was enhanced by NPF RNAi (<i>DvPdf-Gal4>Uas-CsChrimson; Uas-NPF RNAi</i>; green line). …"
  14. 1074
  15. 1075
  16. 1076
  17. 1077
  18. 1078
  19. 1079
  20. 1080